Palvella Therapeutics, Inc. (PVLA) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$4,372
Total Return
-56.28%
CAGR
-15.25%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.99% |
| Median | -2.37% |
| Best | +132.82% |
| Worst | -81.24% |
| % of Windows Positive | 44.2% |
1-Year (252 Trading Days)
| Average | +59.54% |
| Median | -47.34% |
| Best | +781.92% |
| Worst | -91.98% |
| % of Windows Positive | 35.3% |
3-Year (756 Trading Days)
| Average | -50.95% |
| Median | -83.71% |
| Best | +127.44% |
| Worst | -97.68% |
| % of Windows Positive | 22.0% |
Risk Metrics
| Maximum Drawdown | -98.60% |
| Average Drawdown | -76.73% |
| Drawdown Duration | 1180 Trading Days (Unrecovered) |
| Sortino Ratio | 0.47 |
| Calmar Ratio | -0.15 |
| CVaR (5%) | -11.34% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +10.27% (+26.10% ann.) | +$1027.02 | $0.00 | $0.00 | $0.00 |
| 2025 | +772.26% | +$77225.78 | $0.00 | $0.00 | $0.00 |
| 2024 | -17.58% | $1758.33 | $0.00 | $0.00 | $0.00 |
| 2023 | -82.50% | $8250.00 | $0.00 | $0.00 | $0.00 |
| 2022 | -72.49% | $7248.68 | $0.00 | $0.00 | $0.00 |
| 2021 | +51.20% | +$5119.99 | $0.00 | $0.00 | $0.00 |
| 2020 | -30.94% | $3093.92 | $0.00 | $0.00 | $0.00 |
| 2019 | +36.09% | +$3609.02 | $0.00 | $0.00 | $0.00 |
| 2018 | -64.77% | $6476.82 | $0.00 | $0.00 | $0.00 |
| 2017 | +437.37% | +$43736.67 | $0.00 | $0.00 | $0.00 |
| 2016 | -38.65% | $3864.63 | $0.00 | $0.00 | $0.00 |
| 2015 partial | -16.73% (-16.82% ann.) | $1672.73 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | January 2, 2015 – February 19, 2020 | +36.36% | +6.23% | +$3636.36 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -46.68% | -99.92% | $4668.37 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +12.83% | +21.44% | +$1283.19 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +23.42% | +22.09% | +$2342.01 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -70.52% | -72.66% | $7051.52 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -79.50% | -57.48% | $7950.49 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +614.23% | +216.65% | +$61422.78 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.